Fabino Life Sciences Ltd - 543444 - Notice Of 11Th Annual General Meeting (AGM) To Be Held On Thursday, September 22, 2022.
Please find attached herewith the Notice of 11th Annual General Meeting along with the annexure, to be held on Thursday, September 22, 2022 at 11.00 A.M. to transact the business specified. You are requested to kindly update above information on your record. Fabino Life Sciences Ltd - 543444 - Intimation Of Book Closure For 11Th Annual General Meeting
We would like to inform you that the Register of Members & Share Transfer Books of the Company will remain closed from Friday, September 16, 2022 to Thursday, September 22, 2022 (both days inclusive) for the purpose of 11th Annual General Meeting (AGM) of the Company to be held on Thursday, September 22, 2022. Kindly acknowledge the same and update your record. Fabino Life Sciences Ltd - 543444 - Appointment of Company Secretary and Compliance Officer
Pursuant to Regulation 30 read with Schedule III of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015, we wish to inform you that, Board has appointed in its meeting held today CS Aslam Mohammad as Company Secretary and Compliance Officer w.e.f August 11, 2022 in replacement of CS Jeel Poshiya. The disclosure pursuant to Regulation 30 read with Schedule III of SEBI (LODR) Regulations, 2015 is enclosed as Annexure A. Fabino Life Sciences Ltd - 543444 - Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance Officer
With reference to above stated subject pursuant to Regulation 30 read with Schedule III of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015, we wish to inform you that, CS Jeel Poshiya has tendered her resignation from the Company from her positions held as Company Secretary and Compliance Officer with effect from August 04, 2022 (after closure of business hours)and the matter for succession will be placed before the Board of Directors at their ensuing meeting. Fabino Life Sciences Ltd - 543444 - Intimation For Shifting Of The Registered Office Of The Company
We would like to inform you that consequent to confirmation of the Regional Director, Northern Region, Ministry of Corporate Affairs vide order dated June 29, 2022 for the shifting of Registered Office of the Company from the State of Delhi to the State of Haryana and consequent alteration to the Situation Clause of the Memorandum of Association of the Company, the Board of Directors of the Company has approved shifting of the Registered Office of the Company to Jeevan Vihar extension, Near Shubham Garden, Murthal Road, SonipatHaryana-131001 w.e.f. 25" July, 2022. Fabino Life Sciences Ltd - 543444 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Dear Sir, Please find enclosed herewith the Certificate under Regulation 74(5) of Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018 for the quarter ended June 30, 2022 dated July 11, 2022 received from M/s Bigshare Services Private Limited, the Registrar and Share Transfer Agent of the Company. Kindly acknowledge the receipt. Fabino Life Sciences Ltd - 543444 - Intimation For Shifting Of The Registered Office Of The Company.
We would like to inform you that consequent to confirmation of the Regional Director, Northern Region Ministry of Corporate Affairs New Delhi vide order dated 29.06.2022 for the shifting of Registered Office of the Company from the State of Delhi to the State of Haryana and consequent alteration to the Situation Clause of the Memorandum of Association of the Company, the Board of Directors of the Company has approved shifting of the Registered Office of the Company to 'Jeevan Vihar extension, Near Shubham Garden, Murthal Road, Sonipat, Haryana131001 The Company is in the process of filing necessary forms in this regard with the Ministry of Corporate Affairs. We shall submit a copy of altered Memorandum of Association of the Company upon receipt of the Certificate of Registration from the Registrar of Companies. Fabino Life Sciences Ltd - 543444 - Announcement under Regulation 30 (LODR)-Change in Directorate
Dear Sir/Madam, With reference to the above captioned subject, we wish to inform you that the Board of Directors of the Company at their meeting held today i.e. Tuesday, May 24, 2022 interalia considered the Appointment of Mr. Sumit Malik (DIN: 09615815) as an Additional Director (Non-Executive) of the Company with immediate effect and shall hold office till conclusion of upcoming General Meeting He is not debarred from holding the office of Director by virtue of any order of SEBI or any other such authority. Please find attached the brief profile of Mr. Sumit Malik, enclosed as Annexure A. Kindly acknowledge the receipt of the same and oblige. Fabino Life Sciences Ltd - 543444 - Board Meeting Outcome for Outcome Of Board Meeting Held On 24Th May, 2022
In continuation of our letter dated May 17, 2022, pursuant to regulation 33 read with Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements ) Regulations, 2015, we hereby inform you that the Board of Directors of the Company in its meeting held on 24th May 2022, inter alia considered and approved the following; 1. Submission of Audited Financial Results for Half Year and Year ended March 31, 2022. 2. Appointment of M/s. B B Gusani And Associates (FRN: 140785W) as Internal Auditors of the Company for the F.Y. 2022-23. 3. Appointment of M/s. JNG & CO. Practicing Company Secretaries as Secretarial Auditors of the Company for the F.Y. 2022-23. 4. Appointment of Mr.Sumit Malik (DIN: 09615815) as an Additional Director of the Company with immediate effect and shall hold office till conclusion of upcoming General Meeting. He is not debarred from holding the office of Director by virtue of any order of SEBI or any other such authority. Fabino Life Sciences Ltd - 543444 - Board Meeting Intimation for Intimation Of Board Meeting For Consideration And Approval Of Audited Financial Results For Half Year And Financial Year Ended March 31, 2022 And Closure Of Trading Window
Fabino Life Sciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 24/05/2022 ,inter alia, to consider and approve In pursuant to Regulation 29(1) of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015 this is to inform you, that a meeting of the Board of Directors of Fabino Life Sciences Limited is scheduled to be held on Tuesday, May 24, 2022 at Registered Office of the Company at 105, Plot No 12, Barodia Tower, 1st Floor, D Block, Central Market, Prashant Vihar, New Delhi- 110085, inter-alia to discuss and approve, among other items, the Audited Financial Results and Statement of Assets and Liabilities for Half Year and Financial Year Ended March 31, 2022. Further, in terms of the Code of Conduct of Company adopted under SEBI (Prohibition of Insider Trading) Regulations, 2015 the trading window for dealing in the securities of the Company is already closed and shall open 48 hours after conclusion of the Board Meeting. Kindly acknowledge and oblige.